[artículo] 
inJournal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 3 (Junio) . - pp. 294-299

Título :	Duration of imipramine therapy and relapse in panic disorder with agoraphobia
Tipo de documento:	texto impreso
Autores:	Matig Mavissakalian, Autor ; James Perel, Autor
Fecha de publicación:	2023
Artículo en la página:	pp. 294-299
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Agorafobia, Agentes antidepresivos tricíclicos, Imipramina, Trastorno de pánico.
Resumen:	It has been suggested that maintenance treatment of patients who have remitted panic disorder with agoraphobia beyond the six months of acute phase imipramine treatment may decrease the risk of relapse. This study further explores the relationship between relapse and duration of imipramine treatment in this population.
Link:	./index.php?lvl=notice_display&id=31069

[artículo] Duration of imipramine therapy and relapse in panic disorder with agoraphobia [texto impreso] / Matig Mavissakalian, Autor ; James Perel, Autor . - 2023 . - pp. 294-299.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 3 (Junio) . - pp. 294-299

Palabras clave:	Agorafobia, Agentes antidepresivos tricíclicos, Imipramina, Trastorno de pánico.
Resumen:	It has been suggested that maintenance treatment of patients who have remitted panic disorder with agoraphobia beyond the six months of acute phase imipramine treatment may decrease the risk of relapse. This study further explores the relationship between relapse and duration of imipramine treatment in this population.
Link:	./index.php?lvl=notice_display&id=31069